Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWest.brom 6.15% Regulatory News (WBS)

Share Price Information for West.brom 6.15% (WBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 84.50
Bid: 82.00
Ask: 87.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.098%)
Open: 84.50
High: 84.50
Low: 84.50
Prev. Close: 84.50
WBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Reorganisation

6 Apr 2018 11:00

RNS Number : 1091K
West Bromwich Building Society
06 April 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OR ITS TERRITORIES, AUSTRALIA, SOUTH AFRICA, JAPAN, HONG KONG, SINGAPORE, ITALY, SWITZERLAND OR CANADA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF SUCH JURISDICTION

Regulatory News Announcement

For Immediate Release6 April 2018

West Bromwich Building Society[1]INDICATIVE RESULTS OF Liability Management Exercise

This announcement contains inside information.

In an announcement dated 8 March 2018 (the "March Announcement"), West Bromwich Building Society (the "Society") announced the launch of its liability management exercise (the "Liability Management Exercise" or "LME") in relation to its 3,650 Profit Participating Deferred Shares (the "PPDS") and its £75 million 6.15 per cent. Permanent Interest Bearing Shares (the "PIBS").

The LME consists of the PPDS Exchange Offer and the PIBS Exchange Offer (together, the "Exchange Offers"), the PIBS Tender Offer (together with the Exchange Offers, the "Offers") and the Variations, in each case as defined in the March Announcement. The full terms of the Exchange Offers are set out in a Consent and Exchange Offer Memorandum (the "CEOM") and the full terms of the PIBS Tender Offer are set out in a Consent and Tender Offer Memorandum (the "CTOM"), in each case dated 8 March 2018. Defined terms used and not otherwise defined in this announcement have the meanings given in the March Announcement, the CEOM or the CTOM.

Indicative Results of the LME

The offer period for each of the Offers expired at 3.00 p.m. (London time) on 5 April 2018 (the "Participation Deadline").

As at the Participation Deadline:

(i) a total of 3,650 PPDS (representing 100 per cent. of the total number of PPDS outstanding) had been validly Offered for Exchange pursuant to the PPDS Exchange Offer;

(ii) £58,032,000 in aggregate nominal amount of the PIBS (representing 77.38 per cent. of the aggregate nominal amount of the PIBS outstanding) had been validly Offered for Exchange pursuant to the PIBS Exchange Offer; and

(iii) £8,067,000 in aggregate nominal amount of the PIBS (representing 10.76 per cent. of the aggregate nominal amount of the PIBS outstanding) had been validly tendered for purchase pursuant to the PIBS Tender Offer.

The PPDS Written Resolutions, as set out at Annex B to the CEOM, were passed on 5 April 2018 with the consent in writing of the holders of more than three-quarters of the PPDS. The Society expects to implement the PPDS Written Resolutions and vary the PPDS Conditions accordingly, subject to receiving final approvals for the LME from the Prudential Regulation Authority ("PRA").

Next steps

The PIBS Meeting is scheduled for 5.30 p.m. on 9 April 2018. Following conclusion of the PIBS Meeting, the Society intends to inform the PRA of the final outcome of the LME and to seek the necessary final approvals for the LME. Settlement of the LME will be conditional upon such final approvals being granted.

The Society expects to announce the final results of the LME on or around 10 April 2018.

Further information

The Society appointed Lucid Issuer Services Limited as Information Agent in respect of the LME, as exchange agent for the Exchange Offers and as tabulation agent for the PPDS Written Resolutions and the PIBS Meeting (the "Exchange Agent").

Lucid Issuer Services Limited

Tankerton Works, 12 Argyle Walk

London WC1H 8HA

United Kingdom

Tel: +44 20 7704 0880

Attention: Yves Theis / David Shilson

email: westbrom@lucid-is.com

The Society appointed Equiniti Limited as tender agent for the PIBS Tender Offer (the "PIBS Tender Agent"):

Equiniti Limited

Corporate Actions

Aspect House

Spencer Road

Lancing

West Sussex, BN99 6DA

United Kingdom

Evercore Partners International LLP is acting as financial adviser to the Society and Allen & Overy LLP is acting as legal adviser to the Society.

Market Abuse Regulation

This announcement is released by West Bromwich Building Society and contains information that qualifies or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the Liability Management Exercise described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, the person responsible for arranging the release of this announcement on behalf of West Bromwich Building Society is Ashraf Piranie, Group Finance & Operations Director.

Forward-Looking Statements

This announcement and documents referred to in it contain "forward-looking statements" concerning the Society and the Liability Management Exercise. Words such as (without limitation) "expects" and "intends" identify forward-looking statements. There can be no assurance that the matters which are the subject of such forward-looking statements will materialise and no reliance should be placed thereon.

DISCLAIMER

The offer period for each of the Offers has now expired. The Offers have been made outside the United States and otherwise subject to offer restrictions in South Africa, Japan, Hong Kong, Singapore, Italy, Switzerland, Canada and elsewhere.

MiFID II product governance - professional investors and ECPs only target market / PRIIPs Regulation - prohibition of sales to EEA retail investors / COBS 22.2 - restriction on marketing and sales to retail investors

The securities which may be issued pursuant to the LME have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws. Accordingly, the securities are and will be subject to restrictions on transferability and resale and may not be transferred or resold except as permitted under the Securities Act and other applicable securities laws, pursuant to an exemption from registration. Registration rights will not be granted in favour of the securities and they may not be offered, sold, pledged or otherwise transferred except outside the United States in accordance with Rule 903 or Rule 904 of Regulation S.

This announcement and any other materials relating to the Offers may only be communicated to persons in the United Kingdom in circumstances where section 21(1) of the Financial Services and Markets Act 2000 does not apply.

This announcement and any other materials relating to the Offers are and will be for the personal use of authorised recipients only. Under no circumstances should any such documents or materials be reproduced or distributed to any other persons. Persons into whose possession any such documents or materials come are required to inform themselves about and to observe any such restrictions. This announcement and any other materials relating to the Offers do not constitute, and may not be used for the purpose of, an offer or solicitation to the public or to anyone in any jurisdiction in which such offer or solicitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation.


[1] LEI: 45WSBJJYVGC91LG3H515

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CARFKADDCBKKOQK
Date   Source Headline
25th Mar 202412:09 pmRNSAnnouncement to Listing Authorities
30th Nov 20238:00 amRNSHalf-year results for the six months to 30 Sept 23
12th Sep 202312:56 pmRNSAnnouncement to Listing Authorities
1st Aug 20232:14 pmRNSAppointment of Non Executive Director
17th Jul 202311:59 amRNSPARTIAL REPURCHASE OF NOTES - REPLACEMENT
17th Jul 202311:16 amRNSPARTIAL REPURCHASE OF SUBORDINATED FIXED RATE NOTE
26th Jun 20233:54 pmRNSStatement re (add text)
1st Jun 20238:00 amRNSFinal Results
15th May 20232:18 pmRNSNotice of Optional Redemption
13th Mar 20233:02 pmRNSAnnouncement to Listing Authorities
7th Dec 20224:21 pmRNSDirectorate Change
7th Dec 20224:05 pmRNSHalf-year Report
7th Sep 20223:56 pmRNSAnnouncement to Listing Authorities
26th May 20227:30 amRNSDirectorate Change
26th May 20227:30 amRNSFinal Results
9th Mar 20223:32 pmRNSPIBS Interest Payment
24th Nov 20213:04 pmRNSHalf-year Report
24th Nov 20213:03 pmRNSDistribution Announcement CCDS
30th Sep 20219:15 amRNSCancellation of Interest Payments
28th Jul 20213:43 pmRNSDirectorate Change
27th May 20219:07 amRNSDistribution Announcement CCDS
27th May 20218:55 amRNSFinal Results
26th May 20212:03 pmRNSDirectorate Change
18th Mar 20218:44 amRNSCancellation of interest payments
5th Mar 20217:00 amRNSDirectorate Change
30th Dec 202011:46 amRNSBoard Change
26th Nov 20203:29 pmRNSDistribution Announcement CCDS
26th Nov 20203:21 pmRNSHalf-year Report
1st Oct 202010:15 amRNSCancellation of Interest Payments
22nd Jul 20204:06 pmRNSPIBS buy back and cancellation
2nd Jun 20202:16 pmRNSFinal Results
26th Mar 20209:20 amRNSCancellation of Interest Payments
20th Jan 20204:19 pmRNSUpdate on PIBS Distribution Policy
26th Nov 20191:27 pmRNSHalf-year Report
2nd Oct 20192:58 pmRNSCancellation of Interest Payments
29th May 20193:21 pmRNSFinal Results
29th Mar 20192:30 pmRNSCancellation of Interest Payments
6th Dec 20182:34 pmRNSHalf-year Report
26th Sep 20184:51 pmRNSCancellation of Interest Payment
30th May 20183:11 pmRNSFinal Results
10th Apr 201811:00 amRNSCapital Reorganisation
6th Apr 201811:00 amRNSCapital Reorganisation
28th Mar 20183:50 pmRNSCancellation of Interest Payment
8th Mar 20181:15 pmRNSCapital Reorganisation
19th Jan 20183:18 pmRNSProfit Participating Deferred Shares
13th Dec 20171:28 pmRNSCapital Reorganisation
28th Nov 20171:58 pmRNSHalf-year Report
29th Sep 201710:15 amRNSCancellation of Interest Payment
30th May 20172:45 pmRNSFinal Results
25th Apr 201710:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.